SEC Filing Details

We are a clinical-stage biopharmaceutical company leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving cell and gene therapies for patients with high unmet medical need.

SEC Filing Details

Document Details

Form
Filing Date
Feb 18, 2022
Document Date
Feb 18, 2022
Form Description
Securities offered to employees pursuant to employee benefit plans
Filing Group
Registration Statements
Company
Poseida Therapeutics, Inc.
Issuer
Poseida Therapeutics, Inc.